6-Bromo-2-chloroquinoline-3-carbaldehyde is a halogenated quinoline derivative featuring both bromo and chloro substituents, along with a formyl group at the 3-position. This specific substitution pattern makes it a versatile and valuable bifunctional building block in organic synthesis. Its primary application is as a key pharmaceutical intermediate. The molecule serves as a crucial precursor in the synthesis of various biologically active compounds, particularly kinase inhibitors. For instance, it is a documented intermediate in the synthesis of potent and selective inhibitors targeting kinases such as c-Met and ALK, which are important in cancer therapy research. The reactive aldehyde and halogen sites allow for sequential functionalization to construct complex heterocyclic scaffolds found in many drug candidates. As a synthetic intermediate, it is commercially available from suppliers specializing in advanced pharmaceutical intermediates and fine chemicals for medicinal chemistry. Its utility stems from the orthogonal reactivity of the bromo and chloro groups, enabling selective cross-coupling reactions, and the aldehyde group, which is amenable to condensation and further derivatization.